Literature DB >> 10940279

A reproducible grading scale for histological assessment of inflammation in ulcerative colitis.

K Geboes1, R Riddell, A Ost, B Jensfelt, T Persson, R Löfberg.   

Abstract

BACKGROUND: Evaluation of histological activity in ulcerative colitis needs to be reproducible but has rarely been tested. This could be useful both clinically and in clinical trials. AIM: To develop reproducible criteria which are valid in the assessment of acute inflammation (activity) and chronicity, and to evaluate these features in an interobserver variability study.
METHODS: A six grade classification system for inflammation was developed which could also be fine tuned within each grade. The grades were: 0, structural change only; 1, chronic inflammation; 2, lamina propria neutrophils; 3, neutrophils in epithelium; 4, crypt destruction; and 5, erosions or ulcers. Ninety nine haematoxylin-eosin sections from endoscopically inflamed and non-inflamed mucosa from patients with distal ulcerative colitis were assessed in two separate readings by three pathologists independently and without knowledge of the clinical status. Interobserver agreement was compared pairwise using kappa statistics.
RESULTS: Initially, kappa values between the observers were 0.20, 0.42, and 0.26, which are too low to be of value. Following development of a semiquantitative pictorial scale for each criterion, kappa values improved to 0.62, 0.70, and 0.59. For activity defined by neutrophils between epithelial cells, kappa values were 0.903, 1.000, and 0.907. Complete agreement was reached in 64% of samples of endoscopically normal and in 66% of endoscopically inflamed tissue. Neutrophils in epithelium correlated with the presence of crypt destruction and ulceration.
CONCLUSION: A histological activity system was developed for ulcerative colitis that showed good reproducibility and modest agreement with the endoscopic grading system which it complemented. It has potential value both clinically and in clinical trials.

Entities:  

Mesh:

Year:  2000        PMID: 10940279      PMCID: PMC1728046          DOI: 10.1136/gut.47.3.404

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Histologic and colonoscopic assessment of disease extension in ulcerative colitis.

Authors:  C H Florén; C Benoni; R Willén
Journal:  Scand J Gastroenterol       Date:  1987-05       Impact factor: 2.423

2.  What is colitis? Statistical approach to distinguishing clinically important inflammatory change in rectal biopsy specimens.

Authors:  D Jenkins; A Goodall; K Drew; B B Scott
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

3.  Correlation of histopathologic evidence of disease activity with the presence of immunoglobulin-containing cells in the colons of patients with inflammatory bowel disease.

Authors:  D F Keren; H D Appelman; W O Dobbins; J J Wells; B Whisenant; J Foley; R Dieterle; K Geisinger
Journal:  Hum Pathol       Date:  1984-08       Impact factor: 3.466

4.  A quantitative method of estimating inflammation in the rectal mucosa. IV. Ulcerative colitis in remission.

Authors:  C A Rubio; C Johansson; A Uribe; Y Kock
Journal:  Scand J Gastroenterol       Date:  1984-06       Impact factor: 2.423

5.  Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis.

Authors:  J Powell-Tuck; D W Day; N A Buckell; J Wadsworth; J E Lennard-Jones
Journal:  Dig Dis Sci       Date:  1982-06       Impact factor: 3.199

6.  A quantitative method of estimating inflammation in the rectal mucosa. II. Normal limits in symptomatic patients.

Authors:  C A Rubio; C Johansson; Y Kock
Journal:  Scand J Gastroenterol       Date:  1982-11       Impact factor: 2.423

7.  A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis.

Authors:  A Danielsson; G Hellers; E Lyrenäs; R Löfberg; A Nilsson; O Olsson; S A Olsson; T Persson; L Salde; J Naesdal
Journal:  Scand J Gastroenterol       Date:  1987-10       Impact factor: 2.423

8.  Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets.

Authors:  R Wright; S R Truelove
Journal:  Am J Dig Dis       Date:  1966-11

9.  Circulating and tissue eosinophils in ulcerative colitis.

Authors:  R Wright; S C Truelove
Journal:  Am J Dig Dis       Date:  1966-11

10.  Histopathology differentiates acute self-limited colitis from ulcerative colitis.

Authors:  T T Nostrant; N B Kumar; H D Appelman
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

View more
  223 in total

1.  Changes in chemical coding of myenteric neurones in ulcerative colitis.

Authors:  M Neunlist; P Aubert; C Toquet; T Oreshkova; J Barouk; P A Lehur; M Schemann; J P Galmiche
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis.

Authors:  Tarang Taghvaei; Iradj Maleki; Farshad Nagshvar; Hafez Fakheri; Vahid Hosseini; Seyed Mohammad Valizadeh; Hassan Neishaboori
Journal:  Intern Emerg Med       Date:  2014-11-04       Impact factor: 3.397

3.  B1a lymphocytes in the rectal mucosa of ulcerative colitis patients.

Authors:  Lino Polese; Riccardo Boetto; Giuseppe De Franchis; Imerio Angriman; Andrea Porzionato; Lorenzo Norberto; Giacomo Carlo Sturniolo; Veronica Macchi; Raffaele De Caro; Stefano Merigliano
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

Review 4.  Intestinal mucosal responses to microbial infection.

Authors:  Lars Eckmann; Martin F Kagnoff
Journal:  Springer Semin Immunopathol       Date:  2005-06-01

5.  Enterotoxigenicity of mature 45-kilodalton and processed 35-kilodalton forms of hemagglutinin protease purified from a cholera toxin gene-negative Vibrio cholerae non-O1, non-O139 strain.

Authors:  A Ghosh; D R Saha; K M Hoque; M Asakuna; S Yamasaki; H Koley; S S Das; M K Chakrabarti; A Pal
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  Assessment of Disease Severity and Role of Cytomegalo Virus Infection in Patients with Ulcerative Colitis.

Authors:  Nobin Babu Kalappurayil; Jino Thomas; Baburajan Mankuni; Varghese Thomas
Journal:  J Clin Diagn Res       Date:  2017-03-01

7.  Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial.

Authors:  Iris Dotan; Etgar Levy-Nissenbaum; Yehuda Chowers; Alexander Fich; Eran Israeli; Tomer Adar; Shimon Shteingart; Hermona Soreq; Eran Goldin
Journal:  Dig Dis Sci       Date:  2016-08-29       Impact factor: 3.199

8.  Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.

Authors:  Burton I Korelitz; Keith Sultan; Megha Kothari; Leo Arapos; Judy Schneider; Georgia Panagopoulos
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

9.  Chronic HIV Infection Is Associated with Upregulation of Proinflammatory Cytokine and Chemokine and Alpha Defensin Gene Expression in Colorectal Mucosa.

Authors:  Jennifer Mait-Kaufman; Esra Fakioglu; Pedro M M Mesquita; Julie Elliott; Yungtai Lo; Rebecca Pellett Madan
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-08       Impact factor: 2.205

10.  Inflammatory bowel disease register: Steps towards Crohn's & colitis foundation of Saudi Arabia (CCFSA).

Authors:  Ibrahim Masoodi; Khalid Alsayari; Jamal Albishri
Journal:  Int J Health Sci (Qassim)       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.